Cargando…
Bradbury CA, Craig Z, Cook G, et al. Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials. Blood. 2020;136(9):1091-1104.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555419/ https://www.ncbi.nlm.nih.gov/pubmed/33091138 http://dx.doi.org/10.1182/blood.2020009029 |
Ejemplares similares
-
Berzuini A, Bianco C, Paccapelo C, et al. Red cell–bound antibodies and transfusion requirements in hospitalized patients with COVID-19. Blood. 2020;136(6):766-768.
Publicado: (2022) -
Bradbury Thompson : the art of graphic design /
por: Thompson, Bradbury
Publicado: (1988) -
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial
por: Jones, J R, et al.
Publicado: (2016) -
Malcovati L, Stevenson K, Papaemmanuil E, et al. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. Blood. 2020;136(2):157-170.
Publicado: (2021) -
Erratum to: Hypophosphatemic osteomalacia: an unusual clinical presentation of multiple myeloma
por: Reyskens, M., et al.
Publicado: (2015)